Article: AIDSVAX is safe, but efficacy question remains.

AIDSVAX is safe, but efficacy question remains

VaxGen founder discusses quest for AIDS vaccine

(Editor's note: AIDS Alert asked Donald P. Francis, MD, DSc, president and co-founder of VaxGen of Brisbane, CA, to answer questions about his companys phase III clinical trials of AIDSVAX, the AIDS vaccine that is furthest along in development. In the interview below, Francis describes the current status of AIDSVAX and the obstacles that still must be overcome before a successful AIDS vaccine is brought to market. Francis previously has worked as an infectious disease investigator with the Centers for Disease Control and Prevention in Atlanta, and was ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!